
    
      The drug being tested in this survey is called trelagliptin tablet. This tablet is being
      tested to treat people who have type 2 diabetes mellitus.

      This survey is an observational (non-interventional) study and will look at the long-term
      safety and efficacy of the trelagliptin tablet in the routine clinical setting. The planned
      number of observed patients will be approximately 3000.

      This multi-center observational trial will be conducted in Japan.
    
  